Gene-Guided cancer drug trial aims to match right patients to right treatment
NCT ID NCT04273061
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tests the drug atezolizumab in about 200 adults with different incurable solid tumors. Researchers use each person's tumor DNA and RNA to see if their cancer might respond to the drug. Participants receive the same dose every 3 weeks, and the study checks if the genetic clues actually predict who benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Health Network / Princess Margaret Cancer Centre
WITHDRAWNToronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.